ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRI Albany Molecular Research, Inc.

21.74
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Albany Molecular Research, Inc. NASDAQ:AMRI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 21.74 21.74 21.76 0 01:00:00

Lifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolut...

07/09/2016 9:06pm

PR Newswire (US)


Albany Molecular Research, Inc. (NASDAQ:AMRI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Albany Molecular Research, Inc. Charts.

NEW YORK, Sept. 7, 2016 /PRNewswire/ -- Accuride Corporation (ACW)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of ACW to funds managed by Crestview Partners for $2.58 per share.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Albany Molecular Research Inc. (AMRI)

Lifshitz & Miller announces investigation on behalf of AMRI investors.  Specifically, on July 26, 2016, the Court denied a motion to dismiss a securities fraud class action filed against AMRI.  The action alleges that between August 5, 2014 and November 5, 2014, AMRI concealed from shareholders that a power outage at an acquired laboratory had contaminated the inventory.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Emergent BioSolutions, Inc. (EBS)

Lifshitz & Miller announces investigation on behalf of EBS investors.  The investigation relates to EBS' awareness of future lucrative contract renewals and demand from the U.S. government for EBS' anthrax vaccine BioThrax.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Flowers Foods, Inc. (FLO)

Lifshitz & Miller announces investigation on behalf of FLO investors.  The investigation relates to whether FLO was improperly classifying employees as independent contractors.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Orbital ATK, Inc. (OA)

Lifshitz & Miller announces investigation on behalf of OA investors.  The investigation concerns whether OA lacked effective control over financial reporting.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Quorum Health Corp. (QHC)

Lifshitz & Miller announces investigation on behalf of QHC investors.  Specifically, on May 11, 2016, Quorum stated its 2016 guidance revenues ranging between $2.2 billion to $2.3 billion. On August 10, 2016, QHC decreased its 2016 guidance revenues ranging $2.15 billion to $2.20 billion.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Stericycle, Inc. (SRCL SRCLP)

Lifshitz & Miller announces investigation on behalf of SRCL investors.  The investigation relates to whether SRCL inflated its revenues and growth by improperly raising the rates it charged smaller customers.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

SunPower Corporation (SPWR)

Lifshitz & Miller announces investigation on behalf of SPWR investors.  The investigation concerns whether a substantial number of SunPower's customers were adopting a longer-term timeline for project completion.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-accuride-corporation-albany-molecular-research-inc-emergent-biosolutions-inc-flowers-foods-inc-orbital-atk-inc-quorum-health-corp-stericycle-inc-and-sunpower-c-300324179.html

SOURCE Lifshitz & Miller Law Firm

Copyright 2016 PR Newswire

1 Year Albany Molecular Research, Inc. Chart

1 Year Albany Molecular Research, Inc. Chart

1 Month Albany Molecular Research, Inc. Chart

1 Month Albany Molecular Research, Inc. Chart

Your Recent History

Delayed Upgrade Clock